Uteine fibroids

Mahmadiyorova Ziyoda Shodiyor's Daughter, Mahmadiyeva Dilfuza Nasiriddinovna
2023 · doi:10.5281/zenodo.8382084 · W6931631167
Review OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-09 · read from full text ⓘ

This article provides a general overview of uterine fibroids, also known as leiomyomas, which are noncancerous growths in the uterus affecting many women during their reproductive years. The authors discuss the multifaceted nature of the condition, exploring its potential causes, associated symptoms such as heavy menstrual bleeding and pelvic pain, and various treatment options available to manage these issues. By reviewing existing literature on the impact of fibroids on women's health and fertility, the paper aims to serve as an informative guide for patients navigating diagnosis and care. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Uterine fibroids, also known as leiomyomas, are a prevalent gynecological condition that affects a significant number of women during their reproductive years. These noncancerous growths, arising in the uterus, can lead to a range of symptoms, including heavy menstrual bleeding, pelvic pain, and even fertility issues. This article delves into the multifaceted world of uterine fibroids, exploring their causes, symptoms, and various treatment options. Article also serves as an informative guide, empowering women to navigate the complex landscape of uterine fibroids, make informed decisions, and take proactive steps toward improved reproductive health and overall well-being.
Full text 2,647 characters · extracted from oa-doi-fallback · click to expand
Published September 27, 2023 | Version v1 Journal article Open Uteine fibroids - 1. Tashkent Medical Academy, student of group 511, direction of Treatment - 2. National University named after Mirzo Ulug'bek, student of group SBBU 21_ 02, Faculty of Biology. Description Uterine fibroids, also known as leiomyomas, are a prevalent gynecological condition that affects a significant number of women during their reproductive years. These noncancerous growths, arising in the uterus, can lead to a range of symptoms, including heavy menstrual bleeding, pelvic pain, and even fertility issues. This article delves into the multifaceted world of uterine fibroids, exploring their causes, symptoms, and various treatment options. Article also serves as an informative guide, empowering women to navigate the complex landscape of uterine fibroids, make informed decisions, and take proactive steps toward improved reproductive health and overall well-being. Files 397-404 Mahmadiyorova Ziyoda.pdf Files (787.2 kB) | Name | Size | Download all | |---|---|---| | md5:1400e9c1f2ad8592e85d9bd2b05d4f9a | 787.2 kB | Preview Download | Additional details References - 1. Stewart, E. A. (2001). Uterine fibroids. The Lancet, 357(9252), 293-298. - 2. Baird, D. D., Dunson, D. B., & Hill, M. C. (2003). High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. American Journal of Obstetrics and Gynecology, 188(1), 100-107. - 3. Wise, L. A., Laughlin-Tommaso, S. K., & Wellons, M. F. (2016). Uterine leiomyoma: Understanding the impact on women's health. Fertility and Sterility, 106(2), 421-432. - 4. Bulun, S. E. (2013). Uterine fibroids. New England Journal of Medicine, 369(14), 1344-1355. - 5. Marsh, E. E., & Al-Hendy, A. (2012). Uterine leiomyoma: Impact on reproductive health. Obstetrics and Gynecology Clinics, 39(4), 521-533. - 6. Pritts, E. A., & Parker, W. H. (2012). Uterine fibroids: An overview. Obstetrics and Gynecology, 120(2 Pt 1), 347-355. - 7. Stewart, E. A., & Laughlin-Tommaso, S. K. (2016). Cervical and uterine factor infertility. Obstetrics and Gynecology Clinics, 43(1), 29-39. - 8. Cardozo, E. R., & Clark, A. D. (2012). Use of oral contraceptives for management of menstrual-related symptoms in the United States. Journal of Women's Health, 21(3), 339-342. - 9. Donnez, J., Dolmans, M. M., & Uterine fibroid management: From the present to the future. Human Reproduction Update, 22(6), 665-686. - 10. Froeling, F. E., & Lethaby, A. (2013). Gonadotrophin-releasing hormone analogue (GnRHa) therapy for uterine fibroids before surgery. The Cochrane Database of Systematic Reviews, 11(11), CD000547.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T10:27:25.814695+00:00
License: CC0 · commercial use OK